Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Michal M. Lotem"'
Publikováno v:
Case Reports in Surgery, Vol 2013 (2013)
Background. Visceral metastatic spread of ocular melanoma most commonly occurs via hematogenous route to the liver. Lymphatic spread of ocular melanoma into abdominal lymph nodes has not been reported previously. Case Presentation. A 47-year-old man
Externí odkaz:
https://doaj.org/article/d38c224214d24e008cf704879f0a5026
Publikováno v:
Case Reports in Surgery, Vol 2013 (2013)
Case Reports in Surgery
Case Reports in Surgery
Background. Visceral metastatic spread of ocular melanoma most commonly occurs via hematogenous route to the liver. Lymphatic spread of ocular melanoma into abdominal lymph nodes has not been reported previously.Case Presentation. A 47-year-old man w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c3cf7348a781980d04605eb13dad1d
https://doi.org/10.1155/2013/534730
https://doi.org/10.1155/2013/534730
Autor:
Rubin L; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center Division of Internal Medicine, Jerusalem, Israel limorlaz@gmail.com., Talmon A; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center Division of Internal Medicine, Jerusalem, Israel., Ribak Y; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center Division of Internal Medicine, Jerusalem, Israel., Lavie D; Department of Hematology, Hadassah University Medical Center, Jerusalem, Israel., Nechushtan H; Oncology, Hadassah Medical Center, Jerusalem, Israel.; Hebrew University, Jerusalem, Israel., Caplan N; Department of Radiology, Hadassah University Medical Center, Jerusalem, Israel., Lotem M; Oncology, Hadassah Medical Center, Jerusalem, Israel., Shamriz O; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center, Jerusalem, Israel.; Institute of Medical Research Israel-Canada, Faculty of Medicine, Hebrew University The Lautenberg Center for Immunology and Cancer, Jerusalem, Israel., Adini I; Department of Surgery, Center for Engineering in Medicine and Surgery, Harvard Medical School, Boston, Massachusetts, USA., Tal Y; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center Division of Internal Medicine, Jerusalem, Israel.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Oct 12; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 12.
Autor:
Maimon O; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Nisman B; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel; bnisman@gmail.com., Broier S; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Ben-David I; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Kuznetz A; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Gelfand Y; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Mizrahi A; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Prus E; Department of Hematology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Fuchs I; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Lotem M; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Popovtzer A; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Khutsurauli S; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Meirovitz A; The Legacy Heritage Oncology Center, Soroka University Medical Center, Beer-Sheva, Israel.; Faculty of Medicine, Ben Gurion University of the Negev, Beer-Sheva, Israel., Nechushtan H; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel., Peretz T; Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Publikováno v:
Anticancer research [Anticancer Res] 2024 Aug; Vol. 44 (8), pp. 3543-3550.
Autor:
Christopoulos P; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital and National Center for Tumor Diseases, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, Germany., Harel M; OncoHost Ltd, Binyamina, Israel., McGregor K; OncoHost Ltd, Binyamina, Israel., Brody Y; OncoHost Ltd, Binyamina, Israel., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.; The Roswell Park Comprehensive Cancer Center Data Bank and BioRepository., Bar J; Institute of Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel., Elon Y; OncoHost Ltd, Binyamina, Israel., Sela I; OncoHost Ltd, Binyamina, Israel., Yellin B; OncoHost Ltd, Binyamina, Israel., Lahav C; OncoHost Ltd, Binyamina, Israel., Raveh S; OncoHost Ltd, Binyamina, Israel., Reiner-Benaim A; Department of Epidemiology, Biostatistics and Community Health Sciences, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Reinmuth N; Asklepios Kliniken GmbH, Asklepios Fachkliniken Muenchen, Gauting, Germany.; The German Center for Lung Research (DZL), Munich-Gauting, Germany., Nechushtan H; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Farrugia D; Cheltenham General Hospital, Cheltenham, United Kingdom., Bustinza-Linares E; University of Central Florida, FL., Lou Y; Division of Hematology and Oncology, Mayo Clinic School of Medicine, Jacksonville, FL., Leibowitz R; Shamir Medical Center, Oncology Institute, Zerifin, Israel., Kamer I; Institute of Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel., Zer Kuch A; Department of Oncology, Rambam Medical Center, Haifa, Israel., Moskovitz M; Thoracic Cancer Service, Davidoff Cancer Center, Beilinson, Petah Tikva, Israel., Levy-Barda A; Biobank, Department of Pathology, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel., Koch I; Asklepios Kliniken GmbH, Asklepios Fachkliniken Muenchen, Gauting, Germany., Lotem M; Center for Melanoma and Cancer Immunotherapy, Hadassah Hebrew University Medical Center, Sharett Institute of Oncology, Jerusalem, Israel., Katzenelson R; Kaplan Medical Center, Rehovot, Israel., Agbarya A; Institute of Oncology, Bnai Zion Medical Center, Haifa, Israel., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, United Kingdom., Cheley H; Swansea Bay UHB., Abu-Amna M; Oncology & Hematology Division, Cancer Center, Emek Medical Center, Afula, Israel., Geldart T; Royal Bournemouth Hospital., Gottfried M; Department of Oncology, Meir Medical Center, Kfar-Saba, Israel., Tepper E; Department of Oncology, Assuta Hospital, Tel Aviv, Israel., Polychronis A; Mount Vernon Cancer Centre, Northwood, United Kingdom., Wolf I; Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel., Dicker AP; Thomas Jefferson University, Philadelphia, PA., Carbone DP; Comprehensive Cancer Center, Ohio State University, Columbus, OH., Gandara DR; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Mar; Vol. 8, pp. e2300555.
Autor:
Bar J; Institute of Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel., Leibowitz R; Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.; Shamir Medical Center, Oncology Institute, Zerifin, Israel., Reinmuth N; German Center for Lung Research (DZL), Munich-Gauting, Germany.; Biobank of lung disease, Asklepios Klinik Gauting GmbH, Gauting, Germany., Ammendola A; Biobank of lung disease, Asklepios Klinik Gauting GmbH, Gauting, Germany., Jacob E; OncoHost LTD, Binyamina, Israel., Moskovitz M; Thoracic oncology service, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel., Levy-Barda A; Biobank, Department of Pathology, Rabin Medical Center, Petah Tikva, Israel., Lotem M; Center for Melanoma and Cancer Immunotherapy, Hadassah Hebrew University Medical Center, Sharett Institute of Oncology, Jerusalem, Israel., Katsenelson R; Department of Oncology, Kaplan Medical Center, Rehovot, Israel., Agbarya A; Institute of Oncology, Bnai Zion Medical Center, Haifa, Israel., Abu-Amna M; Oncology & Hematology Division, Cancer Center, Emek Medical Center, Afula, Israel., Gottfried M; Department of Oncology, Meir Medical Center, Kfar-Saba, Israel., Harkovsky T; Barzilai Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Ashkelon, Israel., Wolf I; Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel., Tepper E; Department of Oncology, Assuta Hospital, Tel Aviv, Israel., Loewenthal G; OncoHost LTD, Binyamina, Israel., Yellin B; OncoHost LTD, Binyamina, Israel., Brody Y; OncoHost LTD, Binyamina, Israel., Dahan N; OncoHost LTD, Binyamina, Israel., Yanko M; OncoHost LTD, Binyamina, Israel., Lahav C; OncoHost LTD, Binyamina, Israel., Harel M; OncoHost LTD, Binyamina, Israel., Raveh Shoval S; OncoHost LTD, Binyamina, Israel., Elon Y; OncoHost LTD, Binyamina, Israel., Sela I; OncoHost LTD, Binyamina, Israel., Dicker AP; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States., Shaked Y; Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1364473. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Autor:
Benguigui M; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Cooper TJ; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel; Department of Immunology, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel. Electronic address: timcooper@technion.ac.il., Kalkar P; Department of Human Biology, the Faculty of Natural Sciences, University of Haifa, Haifa, Israel., Schif-Zuck S; Department of Human Biology, the Faculty of Natural Sciences, University of Haifa, Haifa, Israel., Halaban R; Department of Dermatology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA., Bacchiocchi A; Department of Dermatology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA., Kamer I; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Deo A; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Manobla B; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Menachem R; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Haj-Shomaly J; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Vorontsova A; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Raviv Z; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Buxbaum C; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel., Christopoulos P; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, 69126 Heidelberg, Germany; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Heidelberg, Germany., Bar J; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Lotem M; Department of Melanoma and Cancer Immunotherapy, Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Sznol M; Department of Medicine, Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA., Ariel A; Department of Human Biology, the Faculty of Natural Sciences, University of Haifa, Haifa, Israel., Shen-Orr SS; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel; Department of Immunology, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Shaked Y; Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel. Electronic address: yshaked@technion.ac.il.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Feb 12; Vol. 42 (2), pp. 253-265.e12. Date of Electronic Publication: 2024 Jan 04.
Autor:
Jacover A; Hadassah Medical Center, Sharett Institute of Oncology, Jerusalem, Israel., Zarbiv Y; Hadassah Medical Center, Sharett Institute of Oncology, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Hadassah Medical Center, Hadassah Cancer Research Institute, Jerusalem, Israel., Tal KH; Department of Pathology, Hadassah Medical Center, Jerusalem, Israel., Klein S; Hadassah Medical Center, Hadassah Cancer Research Institute, Jerusalem, Israel., Breuer S; Hadassah Medical Center, Sharett Institute of Oncology, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Durst R; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel., Avni B; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Bone-Marrow Transplant, Hadassah Medical Center, Jerusalem, Israel., Grisariu S; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Bone-Marrow Transplant, Hadassah Medical Center, Jerusalem, Israel., Stepensky P; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Bone-Marrow Transplant, Hadassah Medical Center, Jerusalem, Israel., Lotem M; Hadassah Medical Center, Sharett Institute of Oncology, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Hadassah Medical Center, Hadassah Cancer Research Institute, Jerusalem, Israel., Maimon O; Hadassah Medical Center, Sharett Institute of Oncology, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Yablonski-Peretz T; Hadassah Medical Center, Sharett Institute of Oncology, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Publikováno v:
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2023 Dec; Vol. 6 (12), pp. e1894. Date of Electronic Publication: 2023 Sep 26.
Autor:
Schaft N; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Dörrie J; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Schuler G; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany., Schuler-Thurner B; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany., Sallam H; Molecular Genetics and Genetic Toxicology, Health Science Department, American Arab University, Ramallah, Palestine., Klein S; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel., Eisenberg G; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel., Frankenburg S; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel., Lotem M; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel.; Hadassah Cancer Research Institute, Hadassah Hebrew University Hospital, Jerusalem, Israel., Khatib A; Women's Health Research Unit, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Sep 06; Vol. 14, pp. 1248867. Date of Electronic Publication: 2023 Sep 06 (Print Publication: 2023).
Autor:
Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Carlino MS; Melanoma Institute Australia, The University of Sydney, Westmead and Blacktown Hospitals, Sydney, NSW, Australia., McNeil C; Chris O'Brien Lifehouse, Camperdown, NSW, Australia., Ribas A; Jonsson Comprehensive Cancer Center at The University of California, Los Angeles (UCLA), Los Angeles, CA., Grob JJ; Aix-Marseille University, Hospital of the Timone, Marseille, France., Schachter J; Sheba Medical Center-Tel HaShomer, Ramat Gan, Israel., Nyakas M; Oslo University Hospital, Oslo, Norway., Kee D; Austin Health, Heidelberg, VIC, Australia., Petrella TM; Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Blaustein A; Mount Sinai Medical Center Comprehensive Cancer Center, Miami Beach, FL., Lotem M; Sharett Institute of Oncology, Hadassah University Hospital Ein Kerem, Jerusalem, Israel., Arance A; Hospital Clinic Barcelona and IDIBAPS, Barcelona, Spain., Daud AI; UCSF, San Francisco, CA., Hamid O; The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, CA., Larkin J; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Anderson J; Merck & Co, Inc, Rahway, NJ., Krepler C; Merck & Co, Inc, Rahway, NJ., Grebennik D; Merck & Co, Inc, Rahway, NJ., Long GV; Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Aug 20; Vol. 41 (24), pp. 3998-4003. Date of Electronic Publication: 2023 Jun 22.